Portuguese-language VISs
Out-of-date
The translations for some VISs on our website are from previously
published English-language versions that have since been updated.
Unfortunately, IAC is not always able to obtain translations as
updates are issued. Please ensure that your patients receive
information consistent with the current English-language version of
the following VISs.
You are
encouraged to distribute the up-to-date English-language
VIS at the
same time as the translation.
These translations do not
contain the following CDC updates:
- Information was added about MMRV vaccine, tied to the
March 14 MMWR, regarding increased risk of certain adverse events,
including febrile seizures, with MMRV when compared with MMR and
varicella vaccines given separately. Aside from two boxes containing
information about MMRV, both VISs are identical to the previous
editions.
- The new VISs should be used when MMRV is given; but the existing
stocks of the individual MMR and varicella VISs may be used when the
vaccines are given separately.
This translation does not contain the
following CDC updates:
- Section 1: The
answer has been rewritten by CDC.
- Section 2: There
are now 2 doses; the first dose is 12-15 months and the second
dose is 4-6 years.
- CDC added information
on MMRV.
- The URL for Vaccine
Adverse Event Reporting System (VAERS) has changed to www.vaers.hhs.gov.
- The URL for the
National Vaccine Injury Compensation Programs has changed to
www.hrsa.gov/vaccincompensation.
These translations do not contain the following
CDC updates:
- These translations do not contain the following CDC updates
- The main change is in Section 4, which now mentions Tdap.
- The NVICP and VAERS web addresses have also been updated
- The mortality rate for tetanus in Section 1 changed from 1 out of
10, to 2 out of 10 cases.
- The date changed to 5/17/07.
This translation does not contain the
following CDC updates:
- CDC changed the
indication to 1 year or older and has recommended routine use
for children.
- Section 2: Added
persons who work with primates or in research labs to indications
(routine vaccination).
- Added bullet for "persons
who live in communities that have prolonged outbreaks of hepatitis
A."
- Divided the section
into "Who" and "When" parts.
- Removed southern
Europe from list of regions with high rates of hepatitis A.
- Section 3: Added
bullet about allergy to vaccine component.
- Changed wording,
particularly the statement on pregnancy, and made list into
bullets.
- Minor changes to
part 4, 5, and 6 to be consistent with other recent VISs.
- Removed the section
on immune globulin.
These translations do not contain the
following CDC updates:
- On July 18, the CDC posted an interim
VIS for hepatitis B. There are minor changes throughout, but the main
purpose of the update is to emphasize the birth dose for all children.
- A final version will be developed.
These translations do not contain the
following CDC update:
- Changed to "for healthy people from 2 through 49 years of
age." Dated 10/4/07.
- CDC updated the VIS for the
2007-08 season. Only influenza vaccines and the VIS for the
2007-08 season should be used. All influenza vaccines from the
previous season have expired.
Thanks to
the California Department
of Health Services and the Commonwealth of Massachusetts for their
translations.This page was updated on
March 13, 2008 |
Immunization Action Coalition
IAC Home